Welcome to our dedicated page for QADR news (Ticker: QADR), a resource for investors and traders seeking the latest updates and insights on QADR stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect QADR's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of QADR's position in the market.
QDRO Acquisition Corp (Nasdaq: QADRU / QADR) closed its initial public offering of 20,000,000 units at $10.00 per unit on March 30, 2026, raising $200,000,000 in gross proceeds. Units began trading March 27, 2026 on the Nasdaq Global Market under QADRU.
Each unit includes one Class A ordinary share and one-half of a redeemable warrant; whole warrants will trade and are exercisable at $11.50. Cantor Fitzgerald & Co. acted as sole bookrunner and holds a 45-day option to purchase up to an additional 3,000,000 units. The company intends to target businesses in financial services, digital currency and technology. A registration statement was declared effective by the SEC on March 26, 2026.
QDRO Acquisition Corp (NASDAQ:QADR) priced a $200.0 million IPO of 20,000,000 units at $10.00 per unit, with each unit comprising one Class A ordinary share and one-half redeemable warrant. Trading of units under QADRU begins March 27, 2026; offering expected to close March 30, 2026.
The company granted a 45-day option for up to 3,000,000 additional units to cover over-allotments. Whole warrants will be exercisable at $11.50 per share and, once separated, shares and warrants are expected to trade under QADR and QADRW.